WCB-2021-Abstract-Book-150621.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
World Congress of Brachytherapy ONLINE CONGRESS 6-8 May 2021 Radiotherapy &Oncology Journal of the European SocieTy for Radiotherapy and Oncology Volume 158 Supplement 1 (2021) Radiotherapy & Oncology is available online: For ESTRO members: http://www.thegreenjournal.com For institutional libraries: http://www.sciencedirect.com Amsterdam • Boston • London • New York • Oxford • Paris • Philadelphia • San Diego • St. Louis International Standard Serial Number 0167-8140 © 2021 Elsevier B.V. All rights reserved. This journal and the individual contributions contained in it are protected under copyright by Elsevier B.V., and the following terms and conditions apply to their use: Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. For information on how to seek permission visit www.elsevier.com/permissions or call: (+44) 1865 843830 (UK)/(+1) 215 239 3804 (USA). Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations (please consult www. elsevier.com/permissions). Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article (please consult www.elsevier.com/permissions). Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. Orders, claims, and journal inquiries: Please visit our Support Hub page https://service.elsevier.com for assistance. Funding Body Agreements and Policies Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies Available online at www.sciencedirect.com ScienceDirect WCB 2021 ONLINE CONGRESS 6-8 May 2021 Table of contents Teaching Lecture Transrectal ultrasound for gynaecological cancer brachytherapy ...........................................................................(Abs. 0002) Symposium Image guided BT and Outcome for Cervical Cancer: Update from different regions .................................. (Abs. 0003-0006) Brachytherapy physics 2030 – Dosimetry for nuclides and radiation ............................................................ (Abs. 0007-0010) Proffered papers Proffered papers: Breast and cervix ................................................................................................................... (Abs. 0011-0016) Proffered papers: Buccal mucosa and Skin ...................................................................................................... (Abs. 0017-0022) 3 Best Moderated Abstracts ............................................................................................................................... (Abs. 0023-0027) Debate This house believes that combination therapy for intermediate and high-risk prostate cancer represents best standard of care ...................................................................................................................... (Abs. 0029-0033) Symposium Eye/orbital brachytherapy: from organ sparing to function sparing ............................................................. (Abs. 0034-0036) Proffered papers Proffered papers: Prostate Outcome and Treatment Plans ........................................................................... (Abs. 0037-0042) Proffered papers: Optimising treatment .......................................................................................................... (Abs. 0043-0048) Teaching Lecture Using health economics to make the case for brachytherapy – HALYS, QALYS and DALYS ..................................(Abs. 0049) Symposium Single dose vs fractionated HDR monotherapy for prostate cancer .............................................................. (Abs. 0050-0053) Brachytherapy physics 2030 – Enhanced application and in-vivo treatment verification ........................... (Abs. 0054-0057) Proffered Papers Proffered papers: Treatment outcomes cervix ................................................................................................ (Abs. 0058-0063) Proffered papers: Treatment verification ......................................................................................................... (Abs. 0064-0069) Plenary session The next generation of brachytherapists ....................................................................................................................(Abs. 0070) Award lecture Marie Curie Medal .........................................................................................................................................................(Abs. 0072) Symposium 21st century brachytherapy: is it available, affordable and relevant? ........................................................... (Abs. 0073-0076) Debate Partial Breast Irradiation with 1-3 fractions ...................................................................................................... (Abs. 0077-0081) Symposium Accelerated partial breast irradiation - Phase 3 trial results .......................................................................... (Abs. 0082-0085) Head and Neck recurrences after full course Radiotherapy ........................................................................... (Abs. 0086-0088) Teaching lecture How to implement and execute an incident learning system ..................................................................................(Abs. 0089) Debate Optimal treatment for periorificial high risk non-melanoma skin cancer ..................................................... (Abs. 0090-0094) Symposium Guidelines and recommendations in gynaecological cancers ........................................................................ (Abs. 0095-0098) Proffered papers Proffered papers: Urogenital cancers ............................................................................................................... (Abs. 0099-0104) Proffered papers: Imaging and more ................................................................................................................ (Abs. 0105-0110) Proffered papers: Training, GI and Eye ............................................................................................................. (Abs. 0111-0116) Poster presentation GEC-ESTRO Best Poster Presentations .............................................................................................................. (Abs. 0117-0122) Symposium Gastrointestinal brachytherapy ......................................................................................................................... (Abs. 0123-0125) Brachytherapy physics 2030 – Adaptive dose delivery and planning ............................................................ (Abs. 0126-0129) Proffered papers Proffered papers: Dosimetry and quality assurance ....................................................................................... (Abs. 0130-0135) Symposium Brachytherapy: Strategies to improve utilisation in various sites and settings ............................................ (Abs. 0136-0139) Poster presentation Poster Presentation: Gynaecology ..................................................................................................................... (Abs. 0141-0144) Poster Presentation: Physics .............................................................................................................................. (Abs. 0145-0154) Poster Presentation: Prostate ............................................................................................................................ (Abs. 0155-0164) Poster Presentation: Skin ................................................................................................................................... (Abs. 0165-0167) Poster Poster: Breast .....................................................................................................................................................